Migraine is a neurovascular disorder that affects over 1 billion people worldwide. Its
widespread prevalence, and associated disability, have a range of negative and substantial …

Migraine is a disabling primary headache disorder that directly affects more than one billion
people worldwide. Despite its widespread prevalence, migraine remains under-diagnosed …

Migraine is one of more than 200 headache disorders but stands out among these as a
major cause of population ill health. In migraine epidemiology, the key variable is …

The capstone papers on the Global Burden of Disease study 2019 (GBD2019), delayed by a
diversion of resources to mapping covid-19, appeared in Lancet on October 17th. The …

Migraine affects more than one billion individuals each year across the world, and is one of
the most common neurologic disorders, with a high prevalence and morbidity, especially …

Background Neurological disorders account for a large and increasing health burden
worldwide, as shown in the Global Burden of Diseases (GBD) Study 2016. Unpacking how …

Importance Accurate and up-to-date estimates on incidence, prevalence, mortality, and
disability-adjusted life-years (burden) of neurological disorders are the backbone of …

Neurological disorders are the leading cause of disability and the second leading cause of
death worldwide. In the past 30 years, the absolute numbers of deaths and people with …

Background Rimegepant is a calcitonin gene-related peptide receptor antagonist that has
shown efficacy and safety in the acute treatment of migraine. We aimed to compare the …

Epidemiology, the study of diseases in populations, is essential to our understanding of
every aspect of migraine. Migraine epidemiology informs clinical care of patients, shapes …